Navigation Links
Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
Date:12/27/2010

FRAZER, Pa., Dec. 27, 2010 /PRNewswire/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that the company received a second Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the supplemental new drug application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV] for the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.  In its letter to the company, the FDA reiterated its previously stated concerns regarding the NUVIGIL sNDA.  

"Cephalon believes we met the agreed upon safety and efficacy endpoints in the NUVIGIL sNDA clinical study conducted under a Special Protocol Assessment. However, following several conversations with the agency, and given this second complete response letter, the company believes that further communications with the FDA will not result in an approval of this application," said Dr. Lesley Russell, Chief Medical Officer at Cephalon. "As a result, the company is no longer pursuing this indication."

About NUVIGIL NUVIGIL is indicated to improve wakefulness in patients with excessive sleepiness associated with treated obstructive sleep apnea (OSA), shift work disorder (SWD), or narcolepsy.  In patients with OSA, NUVIGIL is used along with airway treatments for this condition.  The NUVIGIL (armodafinil) label includes a bolded warning for serious or life-threatening rash, including Stevens-Johnson Syndrome, requiring hospitalization and discontinuation of treatment, that has been reported in adults in association with the use of modafinil and armodafinil and in children in association with the use of modafinil, a racemic mixture of S and R modafinil (the latter is armodafinil, the active ingredient in NUVIGIL).  NUVIGIL is not approved for use in pediatric patients for any indication. The most common adverse events in controlled c
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
2. Cephalon to Webcast Investor Day
3. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
4. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
5. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
6. Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
7. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
8. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
9. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
10. Cephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
11. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ), ... announce Jennifer Hagerman , Pharm.D., AE-C, senior director ... as the president of the Michigan Pharmacists Association on ... place Feb. 28, 2015, at the MPA Annual Convention ... Center in Detroit, Michigan . Hagerman ...
(Date:12/24/2014)... Dec. 23, 2014 Echo Therapeutics, Inc. ... company focused on skin permeation, continuous glucose monitoring ... W. Hollander has been appointed Chief Executive ... more than 20 years of experience in the ... most recently served as Vice President, Business Development, ...
(Date:12/24/2014)...   Synageva BioPharma Corp. (NASDAQ: ... products for rare disorders, today announced validation by ... Authorization Application (MAA) for sebelipase alfa for LAL ... for accelerated assessment, which has the potential to ... The MAA, and the Biologics License Application ...
Breaking Medicine Technology:Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
... 26, 2011   The World Intellectual Property Organization ... companies and BIO Ventures for Global Health (BVGH), ... consortium where public and private sector organizations share ... global health research community to promote development of ...
... Leading events organiser UBM Live , a division ... a new event, ICSE USA, to be held from May ... USA extends an established global line-up of International Contract Services ... on the pharmaceutical contract services and outsourcing sectors in the ...
Cached Medicine Technology:Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 2Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 3Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 4Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 5Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 6Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 7UBM Live to Roll Out Pharma Contract Services & Outsourcing Brand in the US in 2012 2UBM Live to Roll Out Pharma Contract Services & Outsourcing Brand in the US in 2012 3
(Date:12/25/2014)... York (PRWEB) December 25, 2014 Product ... DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to ... According to an Order issued in the U.S. District ... Court will convene an open conference on January 7, ... United States Courthouse in West Palm Beach, Florida. The ...
(Date:12/25/2014)... The short film “Color of Honor” by young director/producer ... true 9/11 hero, Welles Remy Crowther. It has been chosen ... of Nuremberg International Short Film Festival and the 8th International ... and director Luciana Lagana plays the mother of the ... Gregory Graham - Graham plays a heroic policeman ...
(Date:12/25/2014)... When head lice hits a home or school, parents ... rid of it while keeping it from taking over the ... the solution right in their neighborhood: Lice Troopers . ... full spectrum head lice screening and treatment services to families ... Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , ...
(Date:12/25/2014)... common during the holidays, but there are strategies that can ... arrive at a party hungry. It may seem logical to ... party, but deprivation leads to hunger, and hunger leads to ... Mount Kisco, N.Y., said in a hospital news release. ... to have a snack before attending a party when you ...
(Date:12/25/2014)... December 25, 2014 Thousands of transvaginal ... forward in a number of multidistrict litigations currently underway ... Bernstein Liebhard LLP reports. According to an Order issued ... convene a Joint Status Conference in all of the ... have been directed to submit a proposed agenda to ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... A new study shows that the prevalence of hay fever ... allergic reactions have risen sharply.// ,In the research ... the scientists at the University of Edinburgh have said that ... stabilised, after many years of steady rise but at the ...
... have the unique property or reducing the risk of Alzheimer's disease, ... people in the study, which appears in the latest issue of ... the risk of Alzheimer's was reduced by as much as 76 ... week as compared to those who drank fruit juices only about ...
... The discovery that humans are genetically more suited to being ... discussed in Queenstown// conference by more then 300 leading scientists ... human cell and finding a cure for cancer is also ... Jeremy Hyams, the Convener of the conference says the finding ...
... in the shirt drawer, the time-honored lessons of helping organize ... brain are used to encode such categories as socks, shirts, ... place? ,New research from Harvard Medical School (HMS) investigators ... are found. They report in the advanced online Nature that ...
... North high school, 500 will undergo testing this week following ... will be tested in the coming weeks. ,A ... laboratory tests have now confirmed the boy has tuberculosis. ... parents revealed exposure to the infecting bacteria. The remaining students ...
... the counter but the FDA may soon change that.The FDA ... contain hydroquinone because studies in rats show the possibility that ... of Massachusetts General Hospital said, "I think the FDA is ... the data to show this is not a concern and ...
Cached Medicine News:Health News:Eczema And Hay Fever Decline In UK While Allergic Reactions On The Rise 2Health News:Brain's Filing System Uncovered 2Health News:Brain's Filing System Uncovered 3
... 55 Toric Multifocal soft lens provides ... with all day comfort, ease of ... every distance. This brand new lens ... parameters with ADDs up to +3.00D ...
... this new and innovative stent allows the physician ... at the chair with just topical anesthetic drops., ... and is available in three lengths 25mm, 30mm ... end of the stent is an anchor-shaped head ...
... technology the Technolas 217z Zyoptix System, the ... correction, allows surgeons in the United States ... and astigmatism up to -3.00 Diopters. The ... 2mm and 1mm truncated Gaussian beam, with ...
... IDS OCTEIATM IGF-I kit is a two-site ... Growth Factor-I (IGF-I) in serum or plasma. ... "capture" antibody in microtiter wells and a ... peroxidase. A simple sample pre-treatment replaces acid/ethanol ...
Medicine Products: